Year 2018 (52)

Edition nr. 1-2

Ten years of sitagliptin

  • Sitagliptin is an oral blood glucose lowering agent of the DPP-4 type, intended for use by patients with type 2 diabetes. Its registration has been extended from combination therapy with metformin or with pioglitazone to its use as a monotherap ...

Read article

Ten years of omalizumab

  • Omalizumab was authorised in 2007 for the treatment of severe allergic asthma in adults and children aged 12 years and over. Its authorisation has meanwhile been extended to include the treatment of severe allergic asthma in children aged 6 to ...

Read article


  • Trimbow is a new aerosol combining an inhaled corticosteroid (beclometason) with two bronchodilators, the long-acting β2-agonist formoterol and the muscarinic receptor antagonist (parasympathicolytic) glycopyrronium.
  • Two randomised studies hav ...

Read article